Curexo KRX:060280KOSDAQ
큐렉소 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days3
DART filings, 7 days1
Articles tracked3since Sep 11
In Q2 2026, Curexo reported revenue of ₩23.6bn, up 40.6% year on year, and operating profit of ₩2.4bn. Curexo (큐렉소) appeared in 3 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 11 with 3 articles.
Curexo quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩23.6bn | +40.6% | ₩2.4bn | ₩2.5bn |
| Q1 2026 | ₩16.1bn | -18.3% | −₩913m | ₩458m |
| Q4 2025 derived | ₩20.8bn | +40.2% | ₩1.4bn | ₩1.7bn |
| Q3 2025 | ₩17.2bn | +30.1% | ₩341m | ₩823m |
| Q2 2025 | ₩16.8bn | +24.3% | −₩205m | −₩890m |
| Q1 2025 | ₩19.7bn | +41.4% | ₩843m | ₩1.1bn |
| Q4 2024 derived | ₩14.8bn | -13.4% | −₩1.5bn | −₩5.4bn |
| Q3 2024 | ₩13.2bn | -19.5% | −₩1.4bn | −₩1.6bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Curexo top stories 2 weeks, by number of outlets
- 1
- 2
- 3